カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の整形外科粘弾性サプリメント市場2022年：ヒアルロン酸ナトリウム注射剤、医療用キトサン

◆英語タイトル：Global Orthopaedic Viscoelastic Supplement Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8243 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：94 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

整形外科粘弾性サプリメント市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の整形外科粘弾性サプリメントの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

整形外科粘弾性サプリメント市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ヒアルロン酸ナトリウム注射剤、医療用キトサン

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界の整形外科粘弾性サプリメント市場の主要な市場プレーヤーは以下のとおりです。
・Corneal (Allergan)、Galdermal (Q-Med)、LG Life Science、Bohus BioTech、IMEIK、Bloomage Freda、Shanghai Haohai Biological Technology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、整形外科粘弾性サプリメント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な整形外科粘弾性サプリメントメーカーの企業概要、2019年～2022年までの整形外科粘弾性サプリメントの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な整形外科粘弾性サプリメントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別整形外科粘弾性サプリメントの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの整形外科粘弾性サプリメントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での整形外科粘弾性サプリメント市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および整形外科粘弾性サプリメントの産業チェーンを掲載しています。
・第13、14、15章では、整形外科粘弾性サプリメントの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Corneal (Allergan)、Galdermal (Q-Med)、LG Life Science、Bohus BioTech、IMEIK、Bloomage Freda、Shanghai Haohai Biological Technology
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ヒアルロン酸ナトリウム注射剤、医療用キトサン
・用途別分析2017年-2028年：病院、クリニック、その他
・整形外科粘弾性サプリメントの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・整形外科粘弾性サプリメントのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・整形外科粘弾性サプリメントのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・整形外科粘弾性サプリメントの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・整形外科粘弾性サプリメントの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Orthopaedic Viscoelastic Supplement market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Orthopaedic Viscoelastic Supplement market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Orthopaedic Viscoelastic Supplement global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sodium Hyaluronate Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Orthopaedic Viscoelastic Supplement include Corneal (Allergan), Galdermal (Q-Med), LG Life Science, Bohus BioTech, and IMEIK, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Orthopaedic Viscoelastic Supplement market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sodium Hyaluronate Injection
Medical Chitosan
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Orthopaedic Viscoelastic Supplement market are listed below:
Corneal (Allergan)
Galdermal (Q-Med)
LG Life Science
Bohus BioTech
IMEIK
Bloomage Freda
Shanghai Haohai Biological Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orthopaedic Viscoelastic Supplement product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orthopaedic Viscoelastic Supplement, with price, sales, revenue and global market share of Orthopaedic Viscoelastic Supplement from 2019 to 2022.
Chapter 3, the Orthopaedic Viscoelastic Supplement competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orthopaedic Viscoelastic Supplement breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Orthopaedic Viscoelastic Supplement market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Orthopaedic Viscoelastic Supplement.
Chapter 13, 14, and 15, to describe Orthopaedic Viscoelastic Supplement sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Orthopaedic Viscoelastic Supplement Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orthopaedic Viscoelastic Supplement Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Sodium Hyaluronate Injection
1.2.3 Medical Chitosan
1.3 Market Analysis by Application
1.3.1 Overview: Global Orthopaedic Viscoelastic Supplement Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Orthopaedic Viscoelastic Supplement Market Size & Forecast
1.4.1 Global Orthopaedic Viscoelastic Supplement Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Orthopaedic Viscoelastic Supplement Sales in Volume (2017-2028)
1.4.3 Global Orthopaedic Viscoelastic Supplement Price (2017-2028)
1.5 Global Orthopaedic Viscoelastic Supplement Production Capacity Analysis
1.5.1 Global Orthopaedic Viscoelastic Supplement Total Production Capacity (2017-2028)
1.5.2 Global Orthopaedic Viscoelastic Supplement Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Orthopaedic Viscoelastic Supplement Market Drivers
1.6.2 Orthopaedic Viscoelastic Supplement Market Restraints
1.6.3 Orthopaedic Viscoelastic Supplement Trends Analysis
2 Manufacturers Profiles
2.1 Corneal (Allergan)
2.1.1 Corneal (Allergan) Details
2.1.2 Corneal (Allergan) Major Business
2.1.3 Corneal (Allergan) Orthopaedic Viscoelastic Supplement Product and Services
2.1.4 Corneal (Allergan) Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Galdermal (Q-Med)
2.2.1 Galdermal (Q-Med) Details
2.2.2 Galdermal (Q-Med) Major Business
2.2.3 Galdermal (Q-Med) Orthopaedic Viscoelastic Supplement Product and Services
2.2.4 Galdermal (Q-Med) Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 LG Life Science
2.3.1 LG Life Science Details
2.3.2 LG Life Science Major Business
2.3.3 LG Life Science Orthopaedic Viscoelastic Supplement Product and Services
2.3.4 LG Life Science Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bohus BioTech
2.4.1 Bohus BioTech Details
2.4.2 Bohus BioTech Major Business
2.4.3 Bohus BioTech Orthopaedic Viscoelastic Supplement Product and Services
2.4.4 Bohus BioTech Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 IMEIK
2.5.1 IMEIK Details
2.5.2 IMEIK Major Business
2.5.3 IMEIK Orthopaedic Viscoelastic Supplement Product and Services
2.5.4 IMEIK Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bloomage Freda
2.6.1 Bloomage Freda Details
2.6.2 Bloomage Freda Major Business
2.6.3 Bloomage Freda Orthopaedic Viscoelastic Supplement Product and Services
2.6.4 Bloomage Freda Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai Haohai Biological Technology
2.7.1 Shanghai Haohai Biological Technology Details
2.7.2 Shanghai Haohai Biological Technology Major Business
2.7.3 Shanghai Haohai Biological Technology Orthopaedic Viscoelastic Supplement Product and Services
2.7.4 Shanghai Haohai Biological Technology Orthopaedic Viscoelastic Supplement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Orthopaedic Viscoelastic Supplement Breakdown Data by Manufacturer
3.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Orthopaedic Viscoelastic Supplement Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Orthopaedic Viscoelastic Supplement
3.4 Market Concentration Rate
3.4.1 Top 3 Orthopaedic Viscoelastic Supplement Manufacturer Market Share in 2021
3.4.2 Top 6 Orthopaedic Viscoelastic Supplement Manufacturer Market Share in 2021
3.5 Global Orthopaedic Viscoelastic Supplement Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Orthopaedic Viscoelastic Supplement Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Orthopaedic Viscoelastic Supplement Market Size by Region
4.1.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Region (2017-2028)
4.1.2 Global Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2028)
4.2 North America Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.3 Europe Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.4 Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.5 South America Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
4.6 Middle East and Africa Orthopaedic Viscoelastic Supplement Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Type (2017-2028)
5.2 Global Orthopaedic Viscoelastic Supplement Revenue by Type (2017-2028)
5.3 Global Orthopaedic Viscoelastic Supplement Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Orthopaedic Viscoelastic Supplement Sales in Volume by Application (2017-2028)
6.2 Global Orthopaedic Viscoelastic Supplement Revenue by Application (2017-2028)
6.3 Global Orthopaedic Viscoelastic Supplement Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
7.2 North America Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
7.3 North America Orthopaedic Viscoelastic Supplement Market Size by Country
7.3.1 North America Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
7.3.2 North America Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
8.2 Europe Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
8.3 Europe Orthopaedic Viscoelastic Supplement Market Size by Country
8.3.1 Europe Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
8.3.2 Europe Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
9.2 Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
9.3 Asia-Pacific Orthopaedic Viscoelastic Supplement Market Size by Region
9.3.1 Asia-Pacific Orthopaedic Viscoelastic Supplement Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
10.2 South America Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
10.3 South America Orthopaedic Viscoelastic Supplement Market Size by Country
10.3.1 South America Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
10.3.2 South America Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Type (2017-2028)
11.2 Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Application (2017-2028)
11.3 Middle East & Africa Orthopaedic Viscoelastic Supplement Market Size by Country
11.3.1 Middle East & Africa Orthopaedic Viscoelastic Supplement Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Orthopaedic Viscoelastic Supplement and Key Manufacturers
12.2 Manufacturing Costs Percentage of Orthopaedic Viscoelastic Supplement
12.3 Orthopaedic Viscoelastic Supplement Production Process
12.4 Orthopaedic Viscoelastic Supplement Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Orthopaedic Viscoelastic Supplement Typical Distributors
13.3 Orthopaedic Viscoelastic Supplement Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Orthopaedic Viscoelastic Supplement Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Orthopaedic Viscoelastic Supplement Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Corneal (Allergan) Basic Information, Manufacturing Base and Competitors
Table 4. Corneal (Allergan) Major Business
Table 5. Corneal (Allergan) Orthopaedic Viscoelastic Supplement Product and Services
Table 6. Corneal (Allergan) Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Galdermal (Q-Med) Basic Information, Manufacturing Base and Competitors
Table 8. Galdermal (Q-Med) Major Business
Table 9. Galdermal (Q-Med) Orthopaedic Viscoelastic Supplement Product and Services
Table 10. Galdermal (Q-Med) Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. LG Life Science Basic Information, Manufacturing Base and Competitors
Table 12. LG Life Science Major Business
Table 13. LG Life Science Orthopaedic Viscoelastic Supplement Product and Services
Table 14. LG Life Science Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bohus BioTech Basic Information, Manufacturing Base and Competitors
Table 16. Bohus BioTech Major Business
Table 17. Bohus BioTech Orthopaedic Viscoelastic Supplement Product and Services
Table 18. Bohus BioTech Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. IMEIK Basic Information, Manufacturing Base and Competitors
Table 20. IMEIK Major Business
Table 21. IMEIK Orthopaedic Viscoelastic Supplement Product and Services
Table 22. IMEIK Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bloomage Freda Basic Information, Manufacturing Base and Competitors
Table 24. Bloomage Freda Major Business
Table 25. Bloomage Freda Orthopaedic Viscoelastic Supplement Product and Services
Table 26. Bloomage Freda Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shanghai Haohai Biological Technology Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai Haohai Biological Technology Major Business
Table 29. Shanghai Haohai Biological Technology Orthopaedic Viscoelastic Supplement Product and Services
Table 30. Shanghai Haohai Biological Technology Orthopaedic Viscoelastic Supplement Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Orthopaedic Viscoelastic Supplement Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Orthopaedic Viscoelastic Supplement Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Orthopaedic Viscoelastic Supplement, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Orthopaedic Viscoelastic Supplement Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Orthopaedic Viscoelastic Supplement Production Site of Key Manufacturer
Table 36. Orthopaedic Viscoelastic Supplement New Entrant and Capacity Expansion Plans
Table 37. Orthopaedic Viscoelastic Supplement Mergers & Acquisitions in the Past Five Years
Table 38. Global Orthopaedic Viscoelastic Supplement Sales by Region (2017-2022) & (K Units)
Table 39. Global Orthopaedic Viscoelastic Supplement Sales by Region (2023-2028) & (K Units)
Table 40. Global Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Orthopaedic Viscoelastic Supplement Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Orthopaedic Viscoelastic Supplement Sales by Type (2017-2022) & (K Units)
Table 43. Global Orthopaedic Viscoelastic Supplement Sales by Type (2023-2028) & (K Units)
Table 44. Global Orthopaedic Viscoelastic Supplement Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Orthopaedic Viscoelastic Supplement Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Orthopaedic Viscoelastic Supplement Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Orthopaedic Viscoelastic Supplement Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Orthopaedic Viscoelastic Supplement Sales by Application (2017-2022) & (K Units)
Table 49. Global Orthopaedic Viscoelastic Supplement Sales by Application (2023-2028) & (K Units)
Table 50. Global Orthopaedic Viscoelastic Supplement Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Orthopaedic Viscoelastic Supplement Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Orthopaedic Viscoelastic Supplement Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Orthopaedic Viscoelastic Supplement Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Orthopaedic Viscoelastic Supplement Sales by Country (2017-2022) & (K Units)
Table 55. North America Orthopaedic Viscoelastic Supplement Sales by Country (2023-2028) & (K Units)
Table 56. North America Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Orthopaedic Viscoelastic Supplement Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Orthopaedic Viscoelastic Supplement Sales by Type (2017-2022) & (K Units)
Table 59. North America Orthopaedic Viscoelastic Supplement Sales by Type (2023-2028) & (K Units)
Table 60. North America Orthopaedic Viscoelastic Supplement Sales by Application (2017-2022) & (K Units)
Table 61. North America Orthopaedic Viscoelastic Supplement Sales by Application (2023-2028) & (K Units)
Table 62. Europe Orthopaedic Viscoelastic Supplement Sales by Country (2017-2022) & (K Units)
Table 63. Europe Orthopaedic Viscoelastic Supplement Sales by Country (2023-2028) & (K Units)
Table 64. Europe Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Orthopaedic Viscoelastic Supplement Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Orthopaedic Viscoelastic Supplement Sales by Type (2017-2022) & (K Units)
Table 67. Europe Orthopaedic Viscoelastic Supplement Sales by Type (2023-2028) & (K Units)
Table 68. Europe Orthopaedic Viscoelastic Supplement Sales by Application (2017-2022) & (K Units)
Table 69. Europe Orthopaedic Viscoelastic Supplement Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales by Application (2023-2028) & (K Units)
Table 78. South America Orthopaedic Viscoelastic Supplement Sales by Country (2017-2022) & (K Units)
Table 79. South America Orthopaedic Viscoelastic Supplement Sales by Country (2023-2028) & (K Units)
Table 80. South America Orthopaedic Viscoelastic Supplement Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Orthopaedic Viscoelastic Supplement Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Orthopaedic Viscoelastic Supplement Sales by Type (2017-2022) & (K Units)
Table 83. South America Orthopaedic Viscoelastic Supplement Sales by Type (2023-2028) & (K Units)
Table 84. South America Orthopaedic Viscoelastic Supplement Sales by Application (2017-2022) & (K Units)
Table 85. South America Orthopaedic Viscoelastic Supplement Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Orthopaedic Viscoelastic Supplement Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Orthopaedic Viscoelastic Supplement Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales by Application (2023-2028) & (K Units)
Table 94. Orthopaedic Viscoelastic Supplement Raw Material
Table 95. Key Manufacturers of Orthopaedic Viscoelastic Supplement Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Orthopaedic Viscoelastic Supplement Typical Distributors
Table 99. Orthopaedic Viscoelastic Supplement Typical Customers
List of Figures
Figure 1. Orthopaedic Viscoelastic Supplement Picture
Figure 2. Global Orthopaedic Viscoelastic Supplement Revenue Market Share by Type in 2021
Figure 3. Sodium Hyaluronate Injection
Figure 4. Medical Chitosan
Figure 5. Global Orthopaedic Viscoelastic Supplement Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Orthopaedic Viscoelastic Supplement Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Orthopaedic Viscoelastic Supplement Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Orthopaedic Viscoelastic Supplement Sales (2017-2028) & (K Units)
Figure 12. Global Orthopaedic Viscoelastic Supplement Price (2017-2028) & (US$/Unit)
Figure 13. Global Orthopaedic Viscoelastic Supplement Production Capacity (2017-2028) & (K Units)
Figure 14. Global Orthopaedic Viscoelastic Supplement Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Orthopaedic Viscoelastic Supplement Market Drivers
Figure 16. Orthopaedic Viscoelastic Supplement Market Restraints
Figure 17. Orthopaedic Viscoelastic Supplement Market Trends
Figure 18. Global Orthopaedic Viscoelastic Supplement Sales Market Share by Manufacturer in 2021
Figure 19. Global Orthopaedic Viscoelastic Supplement Revenue Market Share by Manufacturer in 2021
Figure 20. Orthopaedic Viscoelastic Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Orthopaedic Viscoelastic Supplement Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Orthopaedic Viscoelastic Supplement Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Orthopaedic Viscoelastic Supplement Sales Market Share by Region (2017-2028)
Figure 24. Global Orthopaedic Viscoelastic Supplement Revenue Market Share by Region (2017-2028)
Figure 25. North America Orthopaedic Viscoelastic Supplement Revenue (2017-2028) & (USD Million)
Figure 26. Europe Orthopaedic Viscoelastic Supplement Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue (2017-2028) & (USD Million)
Figure 28. South America Orthopaedic Viscoelastic Supplement Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Orthopaedic Viscoelastic Supplement Revenue (2017-2028) & (USD Million)
Figure 30. Global Orthopaedic Viscoelastic Supplement Sales Market Share by Type (2017-2028)
Figure 31. Global Orthopaedic Viscoelastic Supplement Revenue Market Share by Type (2017-2028)
Figure 32. Global Orthopaedic Viscoelastic Supplement Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Orthopaedic Viscoelastic Supplement Sales Market Share by Application (2017-2028)
Figure 34. Global Orthopaedic Viscoelastic Supplement Revenue Market Share by Application (2017-2028)
Figure 35. Global Orthopaedic Viscoelastic Supplement Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Orthopaedic Viscoelastic Supplement Sales Market Share by Type (2017-2028)
Figure 37. North America Orthopaedic Viscoelastic Supplement Sales Market Share by Application (2017-2028)
Figure 38. North America Orthopaedic Viscoelastic Supplement Sales Market Share by Country (2017-2028)
Figure 39. North America Orthopaedic Viscoelastic Supplement Revenue Market Share by Country (2017-2028)
Figure 40. United States Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Orthopaedic Viscoelastic Supplement Sales Market Share by Type (2017-2028)
Figure 44. Europe Orthopaedic Viscoelastic Supplement Sales Market Share by Application (2017-2028)
Figure 45. Europe Orthopaedic Viscoelastic Supplement Sales Market Share by Country (2017-2028)
Figure 46. Europe Orthopaedic Viscoelastic Supplement Revenue Market Share by Country (2017-2028)
Figure 47. Germany Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Orthopaedic Viscoelastic Supplement Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Orthopaedic Viscoelastic Supplement Revenue Market Share by Region (2017-2028)
Figure 56. China Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Orthopaedic Viscoelastic Supplement Sales Market Share by Type (2017-2028)
Figure 63. South America Orthopaedic Viscoelastic Supplement Sales Market Share by Application (2017-2028)
Figure 64. South America Orthopaedic Viscoelastic Supplement Sales Market Share by Country (2017-2028)
Figure 65. South America Orthopaedic Viscoelastic Supplement Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Orthopaedic Viscoelastic Supplement Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Orthopaedic Viscoelastic Supplement Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Orthopaedic Viscoelastic Supplement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Orthopaedic Viscoelastic Supplement in 2021
Figure 77. Manufacturing Process Analysis of Orthopaedic Viscoelastic Supplement
Figure 78. Orthopaedic Viscoelastic Supplement Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の整形外科粘弾性サプリメント市場2022年：ヒアルロン酸ナトリウム注射剤、医療用キトサン(Global Orthopaedic Viscoelastic Supplement Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の整形外科粘弾性サプリメント市場2022年：ヒアルロン酸ナトリウム注射剤、医療用キトサン

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp